Roche secured FDA 510(k) clearance for two Cobas Pro Integrated Solutions lab automation units—Cobas c 703 and Cobas ISE Neo—aimed at increasing throughput and reducing workflow friction in high-volume clinical chemistry settings. Roche said the systems can support up to 2,000 tests per hour and provide expanded reagent capacity for more continuous processing. Roche also received CE marking for a molecular Cobas MPX-E blood donor screening assay that consolidates multiple viral targets in a single workflow. The move reinforces continued investment in blood safety automation, particularly where staffing constraints and rising test volumes are increasing operational risk. For labs, the key operational implications are reduced hands-on time, fewer interruptions for reagent reloads, and streamlined multi-target donor screening workflows on Cobas platforms.